Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021: https://mms.businesswire.com/media/20200311005404/en/779090/5/Bancorp_Logo.jpg
Customers Bancorp Listed in Kiplinger’s 6 Best Financial Stocks to Buy in 2021


Customers Bancorp (NYSE:CUBI) was recently identified as one of the “best financial stocks to buy” in 2021 by Kiplinger. The publication looked at the financial sector, one of the hardest-hit

Connection (CNXN) Announces a Special Dividend to Shareholders: https://mms.businesswire.com/media/20200512005920/en/791247/5/Connection_Corp_logo_tall_4c_highres.jpg
Connection (CNXN) Announces a Special Dividend to Shareholders


Connection (PC Connection, Inc.; NASDAQ: CNXN), a leading information technology solutions provider to business, government, and education markets, today announced that its Board of Directors

Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp: https://mms.businesswire.com/media/20191205005702/en/623488/5/LCAM_logo_%28rgb%29.jpg
Koch Real Estate Investments Makes $32 Million Long-Term Investment in Ladder Capital Corp


Ladder Capital Corp (“Ladder” or the “Company”) (NYSE: LADR) announced that an affiliate of Koch Real Estate Investments, LLC exercised its option to invest $32 million in Ladder’s common equity

Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call: https://mms.businesswire.com/media/20191121005110/en/566032/5/Alcoa_logo_horizontal_blue_%282%29.jpg
Alcoa Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call


Alcoa Corporation plans to announce its fourth quarter and full year 2020 financial results on Wednesday, January 20, 2021 after the close of trading on the New York Stock Exchange.



The press

NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical Studies
NOXXON Announces Initiation of NOX-A12 Manufacturing for Future Clinical Studies


Regulatory News:



NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

What Is Time Value of Money?
What Is Time Value of Money?

What Is Time Value of Money? was originally published here.

if (typeof jQuery == 'undefined') { document.write('<scr' + 'ipt type="text/javascript"
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU)

Ennis Will Acquire Assets of Infoseal: https://mms.businesswire.com/media/20191220005069/en/421489/5/EnnisLogo.jpg
Ennis Will Acquire Assets of Infoseal


Ennis, Inc. (the “Company"), (NYSE: EBF), today announced that one of its wholly owned subsidiaries has entered into a Letter of Intent to acquire the assets and assume some liabilities of Infoseal

Insight Awarded Global SASE Partner of the Year from Palo Alto Networks: https://mms.businesswire.com/media/20191108005290/en/699137/5/Insight_Logo__Med.jpg
Insight Awarded Global SASE Partner of the Year from Palo Alto Networks


Insight Enterprises (NASDAQ: NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, was named Palo Alto Networks Global SASE Partner of the Year.

Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24710/Pitney_Bowes.svg.png
Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021


Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that pricing

Angelika Anywhere: Curated for Film Lovers
Angelika Anywhere: Curated for Film Lovers


Reading International, Inc. (NASDAQ: RDI) announces the launch of Angelika Anywhere, a streaming platform curated for film lovers, as inspired by its Angelika Film Center in New York City, North

Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial


Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the company has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for

NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR
NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR


NCR Corporation (NYSE: NCR) leads the global restaurant point-of-sale (POS) software market according to research and consulting firm RBR. The Global POS Software 2020 Report conducted by RBR

Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually


Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in presbyopia, myopia and mydriasis, today announced that it has submitted a New Drug

Essex Property Trust Announces Executive Leadership Succession: https://mms.businesswire.com/media/20191108005660/en/625771/5/Essex_Logo_Black_%28002%29.jpg
Essex Property Trust Announces Executive Leadership Succession


Essex Property Trust, Inc. (NYSE:ESS) announced today the planned succession for the Chief Operating Officer (COO) and the Chief Financial Officer (CFO).



John Burkart will retire as the Company’s

LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDAhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA


Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib) as

US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021: https://mms.businesswire.com/media/20191107005203/en/650770/5/USF_LOGOWITHOUTTAG_RGB_WEB.jpg
US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021


US Foods Holding Corp. (NYSE: USFD) Chairman and Chief Executive Officer, Pietro Satriano, and Chief Financial Officer, Dirk Locascio, will present at the ICR Conference on Monday, Jan. 11 at 1:30

Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations


Eurofins Genomics (Paris:ERF) launches an optimised, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo

 
PRISMAFLEX INTERNATIONAL : Evolution in the capital standing for Anthem Displays
PRISMAFLEX INTERNATIONAL : Evolution in the capital standing for Anthem Displays

Prismaflex partner up with Circle Graphics and maintain a minority holding via their Prismaflex USA subsidiary of 28.91%.

Prismaflex International announce they have concluded an association

 
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021

Lyon, December 28, 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction

Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast: https://mms.businesswire.com/media/20191223005031/en/764313/5/600x100_polaris_black_logo.jpg
Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast


Polaris Inc. (NYSE: PII) announced today that it will release its fourth quarter and full year 2020 financial results on Tuesday, January 26, 2021, and will hold a conference call and webcast at

Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award: https://mms.businesswire.com/media/20200311005404/en/779090/5/Bancorp_Logo.jpg
Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award


Customers Bank was selected as the winner of the highly coveted 2020 Best Example of Making an Impact on Business Award presented by Everbridge, an organization focused on life-saving efforts

Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering
Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering


Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), today announced it has entered into definitive agreements with investors for the purchase and sale of

Lineage Cell Therapeutics Provides End of Year Shareholder Letter : https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg
Lineage Cell Therapeutics Provides End of Year Shareholder Letter


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided a year-end review

Congress Extends Critical Legislation Enabling Employers to Enhance Financial Wellness Programs
Congress Extends Critical Legislation Enabling Employers to Enhance Financial Wellness Programs


Gradifi by E*TRADE, a student loan payment benefit administrator, today applauded Congress’ decision to extend critical legislation that preserves for five years the tax-free status of